Results 241 to 250 of about 3,117,738 (383)

Corrigendum: The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers. [PDF]

Front Cell Dev Biol, 2022
Tan S, Li Z, Li K, Li Y, Liang G, Tang Z, Kang J, Chen W, Li M, Zou Z, Pi G, Zhu X.   +11 more
europepmc   +1 more source

Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma [PDF]

, 1995
Noriharu Shijubo, Yasuhiro Honda, Takuya Fujishima, Hiroki Takahashi, Taku Kodama, Yuichiro Kuroki, Tatsuaki Akino, Shinya Abe   +7 more
openalex   +1 more source

Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models

Advanced Science, Volume 12, Issue 12, March 27, 2025.
Targeting mesothelin (MSLN) improved neoantigen vaccine efficacy in pancreatic cancer by reducing apCAFs, which disrupted the conversion of naive CD4+ T cells into Tregs and enhanced the infiltration of IFN‐γ+CD4+ and GZMK+CD8+ T cells. This combination strengthened neoantigen‐specific T cell response to overcome the immunosuppressive tumor ...
Zhixiong Cai, Zhenli Li, Wenting Zhong, Fangzhou Lin, Xiuqing Dong, Honghao Ye, Yutong Guo, Geng Chen, Xiaoling Yu, Haijun Yu, Ruijing Tang, Xiaolong Liu   +11 more
wiley   +1 more source

Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model. [PDF]

J Thorac Dis, 2021
Hu F, Huang H, Jiang Y, Feng M, Wang H, Tang M, Zhou Y, Tan X, Liu Y, Xu C, Ding N, Bai C, Hu J, Yang D, Zhang Y.   +14 more
europepmc   +1 more source

Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient

, 1994
Gregory J. Tsongalis, Gert S. Faber, Frederic G. Dalldorf, Kenneth J. Friedman, Lawrence M. Silverman, James R. Yankaskas   +5 more
openalex   +1 more source

Metastatic Pattern at Autopsy in non-resectable Adenocarcinoma of the Lung:A Study from a Cohort of 259 Consecutive Patients Treated with Chemotherapy [PDF]

, 1997
Lars Stenbygaard, Jens Benn Sørensen, Jens Olsen   +2 more
openalex   +1 more source

GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy

Advanced Science, EarlyView.
A GRP78 nanobody‐directed immunotoxin suppresses cancer progression and metastasis by enhancing antitumor immunity via STING pathway activation, offering a pan‐cancer‐targeted approach and immunotherapy combination strategy. Abstract The lack of targetable antigens poses a significant challenge in developing effective cancer‐targeted therapies.
Huifang Wang, Runhua Zhou, Chengchao Xu, Lingyun Dai, Rui Hou, Liuhai Zheng, Chunjin Fu, Guangwei Shi, Jingwei Wang, Yang Li, Jinpeng Cen, Xiaolong Xu, Le Yu, Yilei Li, Jigang Wang, Qingfeng Du, Zhijie Li   +16 more
wiley   +1 more source

Three-dimensional and magnified CT images of displaying the imaging features of invasive adenocarcinoma of lung. [PDF]

World J Surg Oncol
Chi J, Wu W, Zhong H, Duan S.
europepmc   +1 more source

Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung

, 1990
Mishal Shaukat, Pamela Hughes
openalex   +1 more source

PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3

Advanced Science, EarlyView.
By decreasing cholesterol and lipid raft levels in the plasma membrane, proprotein convertase subtilisin/kexin type 9 (PCSK9) boosts human epidermal growth factor receptor 1 and 3 (EGFR and HER3) activation, driving tumor growth and metastasis in triple‐negative breast cancer (TNBC).
Tianhong Li, Renfei Wu, Kathy Qian Luo
wiley   +1 more source